Aminoglycosides

On this page

Intro & MOA - Mighty Microbe Mincers

  • Potent bactericidal antibiotics.
  • Spectrum: Primarily aerobic Gram-negative bacilli.
  • Mechanism of Action (MOA):
    • Irreversibly bind to the bacterial 30S ribosomal subunit.
    • Interfere with protein synthesis:
      • Block initiation complex formation.
      • Cause mRNA misreading, leading to abnormal protein insertion.
      • Block translocation of peptidyl-tRNA.
    • Exhibit concentration-dependent killing (↑ conc. = ↑ killing rate).
    • Long Post-Antibiotic Effect (PAE).
    • Oxygen-dependent uptake (ineffective against anaerobes).
  • 📌 Examples: Gentamicin, Neomycin, Amikacin, Tobramycin, Streptomycin (GNATS). Aminoglycoside MOA targeting 30S ribosome

⭐ Aminoglycosides cause misreading of mRNA and block translocation, leading to bactericidal action primarily against aerobic Gram-negative bacteria.

PK/PD Properties - Journey & Jolt

  • Pharmacokinetics (Journey - ADME):
    • Absorption: Poor oral (highly polar); IV/IM administration.
    • Distribution: Accumulates in renal cortex & inner ear (⚠️ nephro/ototoxicity risk).
    • Metabolism: Negligible.
    • Excretion: Renal, via glomerular filtration (unchanged). Adjust dose in renal failure.
  • Pharmacodynamics (Jolt - Effects):
    • Killing: Concentration-Dependent Killing (CDK) - higher $C_{max}$ = faster kill.
    • Duration: Significant Post-Antibiotic Effect (PAE) - suppression post-MIC drop.
  • Dosing Rationale:
    • Once-Daily Dosing (ODD) preferred:
      • Maximizes CDK with high peaks.
      • Utilizes PAE for sustained effect.
      • Minimizes toxicity (drug-free interval for washout from kidney/ear).

⭐ Once-daily dosing regimens leverage concentration-dependent killing and post-antibiotic effect to maximize efficacy and minimize nephrotoxicity.

Clinical Uses & Spectrum - Germ Warfare Gurus

  • Core Spectrum: Serious aerobic Gram-negative bacilli infections (Pseudomonas aeruginosa, E. coli, Klebsiella).

  • Synergy: With β-lactams/Vancomycin for Gram-positive endocarditis (Enterococcus, Staphylococcus).

  • Specific Pathogen Coverage:

    AminoglycosideKey Indications
    StreptomycinTuberculosis (TB), Plague, Tularemia
    GentamicinPlague, Tularemia, Serious Gram-negative sepsis
    AmikacinTB (MDR), Gentamicin-resistant Gram-negatives
    NeomycinBowel sterilization (oral), Topical infections
    TobramycinPseudomonas aeruginosa infections (esp. lungs)

⭐ Aminoglycosides are crucial in combination therapy with cell wall synthesis inhibitors (like penicillin or vancomycin) for synergistic bactericidal activity against certain Gram-positive cocci, especially in endocarditis.

Adverse Effects - Toxic Trio Alert

📌 NNN: Nephrotoxic, Neurotoxic (ototoxic), Neuromuscular blockade.

  • Nephrotoxicity:
    • Reversible acute tubular necrosis (ATN).
    • Monitor: Serum creatinine, BUN. Ensure hydration.
  • Ototoxicity:
    • Irreversible auditory (cochlear: hearing loss, tinnitus) & vestibular (vertigo, ataxia) damage.
    • Dose-related. Monitor audiometry in high-risk/long therapy.
  • Neuromuscular Blockade:
    • Rare; risk of respiratory paralysis.
    • Risk factors: Myasthenia gravis, rapid IV infusion, concurrent neuromuscular blockers, hypocalcemia.
    • Treatment: IV Calcium gluconate or neostigmine.

⭐ Ototoxicity from aminoglycosides can be irreversible and may manifest as hearing loss (cochlear damage) or vertigo/ataxia (vestibular damage).

Resistance & Interactions - Defense Breachers

  • Resistance Mechanisms:
    • Enzymatic modification (acetylation, phosphorylation, adenylation) - most common.
    • Impaired entry.
    • Altered ribosomal binding.
  • Key Interactions & Cautions:
    • Loop diuretics: ↑ ototoxicity.
    • Vancomycin/Amphotericin B: ↑ nephrotoxicity.
    • Neuromuscular blockers: ↑ blockade.
    • Pregnancy: Category D. ⚠️

⭐ Most common resistance: enzymatic drug inactivation by bacterial enzymes.

High‑Yield Points - ⚡ Biggest Takeaways

  • Bactericidal; irreversibly bind 30S ribosome, inhibiting protein synthesis.
  • Spectrum: Aerobic Gram-negative bacilli (e.g., Pseudomonas); synergistic with β-lactams.
  • Major toxicities: Nephrotoxicity (reversible ATN), Ototoxicity (irreversible; cochlear & vestibular), Neuromuscular blockade.
  • Administered IV/IM (poor oral absorption); exhibit significant post-antibiotic effect.
  • Resistance: Primarily via enzymatic modification (acetylation, phosphorylation).
  • Therapeutic Drug Monitoring (TDM) essential due to narrow therapeutic index.

Practice Questions: Aminoglycosides

Test your understanding with these related questions

Anaerobes are resistant intrinsically against which of the following?

1 of 5

Flashcards: Aminoglycosides

1/10

Which drug is used for the treatment of pregnant women with giardiasis?_____

TAP TO REVEAL ANSWER

Which drug is used for the treatment of pregnant women with giardiasis?_____

Paromomycin

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial